Market Tracker

10/02 6:11am ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

7.17
Data as of Oct 01
 -0.51 / -6.64%
Today’s Change
1.68
Today|||52-Week Range
9.56
+184.52%
Year-to-Date

Today’s Trading

Previous close7.68
Today’s open7.67
Day’s range-- - --
Volume424,752
Average volume (3 months)420,349
Market cap$292.2M
Dividend yield--
Data as of 10/01/2014

Growth & Valuation

Earnings growth (last year)-1,300.00%
Earnings growth (this year)+20.71%
Earnings growth (next 5 years)+3.90%
Revenue growth (last year)+38.43%
P/E ratioNM
Price/Sales1.08
Price/Book2.58

Competitors

 Today’s
change
Today’s
% change
XNCRXencor Inc-0.31-3.33%
RGLSRegulus Therapeutics...-0.17-2.49%
SCMPSucampo Pharmaceutic...-0.14-2.15%
IMDZImmune Design Corp+0.45+2.55%
Data as of 10/01/2014

Financials

Next reporting dateNovember 18, 2014
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$84.9M
Annual profit (last year)-$25.6M
Net profit margin-30.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts